Front Matter
(pp. 1–6)
Journal of Economic Perspectives
ISSN 0895-3309 (Print) | ISSN 1944-7965 (Online)
Vol. 39, No. 2, Spring 2025
Find articles in this issue
Economic Markets and Pharmaceutical Innovation
(pp. 3–26)
Patents, Innovation, and Competition in Pharmaceuticals: The Hatch-Waxman Act after 40 Years
(pp. 27–52)
Lessons for the United States from Pharmaceutical Regulation Abroad
(pp. 53–78)
The Economics of Generic Drug Shortages: The Limits of Competition
(pp. 79–102)
Measuring Income and Income Inequality
(pp. 103–26)
Macro Perspectives on Income Inequality
(pp. 127–48)
Public Finance Implications of Economic Inequality
(pp. 149–70)
A Hitchhiker's Guide to Federal Reserve Participation in Fixed Income Markets
(pp. 171–94)
How US Treasuries Can Remain the World's Safe Haven
(pp. 195–214)
US Corporate Bond Markets: Bigger and (Maybe) Better?
(pp. 215–34)
Why Is the Fragmented Municipal Bond Market So Costly to Investors and Issuers?
(pp. 235–60)
Retrospectives: Yair Mundlak and the Fixed Effects Estimator
(pp. 261–74)
Recommendations for Further Reading
(pp. 275–82)